Celltrion
068270.KS
#734
Rank
C$39.70 B
Marketcap
$181.93
Share price
-0.27%
Change (1 day)
1.45%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.04

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.33. In 2022 the company made an earnings per share (EPS) of $4.21 a decrease over its 2021 EPS that were of $5.01.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.04-4.22%
2022$4.21-15.84%
2021$5.0112.77%
2020$4.4470.79%
2019$2.6015.63%
2018$2.25-33.13%
2017$3.36141.17%
2016$1.398.28%
2015$1.2911.28%
2014$1.1616.37%
2013$0.99-67.42%
2012$3.0584.22%
2011$1.6662.13%
2010$1.0280.61%
2009$0.57-559.63%
2008-$0.12-123.16%
2007$0.53